Albumin nanoparticles could serve as a rational tumor-targeted drug delivery system because such nanoparticles would be expected to accumulate in solid tumors via the enhanced permeability and retention (EPR) mechanism when the size range is regulated at around 100 nm [25]. The gene discussed is ALB; the disease is neoplasm.